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Althoughmitochondria are known to be involved in host defense against viral infection, the physiolog-
ical role of mitophagy, a crucial mechanism for maintaining mitochondrial homeostasis, in antiviral im-
munity remains poorly defined. Here, we show that Parkin, a central player in mitophagy, has a vital
function in regulating host antiviral responses. Parkin-knockout mice exhibit improved viral clearance
and survival after viral infection. However, Parkin deficiency does not affect antiviral signaling and
interferon production. Instead, Parkin deficiency augments innate antiviral inflammation by enhancing
mitochondrial ROS (mtROS)-mediated NLRP3 inflammasome activation and promoting viral clear-
ance. Loss of NLRP3 can reverse the enhanced antiviral responses in Parkin knockout mice. Further-
more, we find that Parkin expression is downregulated in peripheral blood mononuclear cells of pa-
tients infected with virus. Collectively, our results suggest that Parkin plays an important role in
antiviral immunity by controlling mtROS-NLRP3 axis-mediated inflammation. These findings provide
physiological insight of the importance of mitophagy in regulating host antiviral response.
INTRODUCTION
The innate immune response plays an essential role in defense against viral infection by the induction of
antiviral cytokines and inflammation (Takeuchi and Akira, 2010). Host recognition of viral infection is medi-
ated by different pattern-recognition receptors (PRRs), including Toll-like receptors (TLRs), RIG-I-like re-
ceptors (RLRs), and DNA sensors (Sun et al., 2010). Upon viral recognition, the PRRs trigger downstream
signaling to activate transcription factors like nuclear factor (NF)-kB and IRFs and induce various inflamma-
tory cytokines (Roers et al., 2016).
Mitochondria are the central hubs of cellular metabolism and have multifunctional roles in bioenergetic
production, apoptosis, signal transduction, and the production of reactive oxygen species (ROS) (Chandel,
2014; Wallace and Fan, 2010). Mitochondria produce cellular ATP and metabolites, which are important in
antiviral immune responses (Mills et al., 2017). Recent studies have shown that mitochondria participate in
innate immune signaling to regulate antiviral responses (Weinberg et al., 2015; West et al., 2011). Mito-
chondria serve as a signaling platform in antiviral innate immunity. The mitochondrial membrane protein
mitochondrial antiviral signaling protein (MAVS) is the central adaptor in RLR signaling and plays an impor-
tant role in defense against RNA viruses (Kawai et al., 2005; Seth et al., 2005; Xu et al., 2005). NLRX1, another
outer mitochondrial membrane (OMM) protein, functions as a negative regulator of inflammation by dis-
rupting the MAVS and TRAF6-mediated pathways in response to viral infection (Allen et al., 2011; Moore
et al., 2008). In addition, some published reports suggest that mitochondrial ROS (mtROS) can directly
modulate antiviral signaling pathway, although its role remains controversial (Agod et al., 2017; Jin
et al., 2010; Tal et al., 2009). Moreover, mtROS acts as an upstream signal to promote activation of the
NLRP3 inflammasome (Zhong et al., 2018; Zhou et al., 2011). The NLRP3 inflammasome has been reported
to drive antiviral inflammation and enhance the host immune response to viral infection (Allen et al., 2009;
Ichinohe et al., 2009; Thomas et al., 2009; Wang et al., 2017).
Virus-induced mtROS is associated with mitochondrial dysfunction. Mitochondrial homeostasis is medi-
ated by mitophagy, which decreases mtROS production by removing impaired mitochondria (Kubli and
Gustafsson, 2012; Tal et al., 2009). Parkin, a cytosolic E3 ubiquitin ligase protein linked with Parkinson dis-
ease (PD), mediates mitophagy in conjunction with the ubiquitin kinase Pink1 that, like Parkin, is also a468 iScience 16, 468–484, June 28, 2019 Crown Copyright ª 2019
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Figure 1. Parkin Deficiency Promotes Viral Clearance without Interfering with IFN Production
(A) WT and Park2/ mice (n = 9) were intranasally infected with VSV at 2 3 108 plaque-forming unit (PFU) per mouse, and the survival rates of mice were
observed and recorded for each day post-infection. Viral titers of lung were determined by standard plaque assay 5 days after infection (n = 8). ELISA analysis
of IFN-b of BALF from WT and Park2/ mice infected with VSV for 12, 24, and 72 h (n = 7 for viral infection, n = 3 for mock infection).
(B) WT and Park2/ mice (n = 10) were intravenously infected with HSV-1 at 6 3 107 PFU per mouse, and the survival rates of mice were observed and
recorded for each day post-infection. Viral titers of lung were determined by standard plaque assay 5 days after infection (n = 8). ELISA analysis of IFN-b of
serum from WT and Park2/ mice infected with HSV-1 for 12, 24, and 72 h (n = 7 for viral infection, n = 3 for mock infection).
(C) RT-qPCR analysis of Ifnb mRNA expression of WT and Park2/ MEFs infected with VSV or HSV-1 at multiplicity of infection (MOI) 1 for 4, 8, and 12 h
(n = 3).NT, no treatment.
(D) ELISA analysis of IFN-b in the supernatants of WT and Park2/ MEFs infected with VSV or HSV-1 at MOI 1 for 12 and 24 h (n = 3). No treatment.
(E) The mtDNA amounts were quantified by RT-qPCR with primers specific for the mitochondrial D loop region or a region of mtDNA that is not inserted into
nuclear DNA (non-NUMT) and primers specific for nDNA (Tert, B2m) inWT and Park2/MEFs infected with VSV or HSV-1 at MOI 10 for 4 h. NT, no treatment.
(F) RT-qPCR analysis of Ddx58, Isg15, and Stat1 mRNA expression of WT and Park2/ MEFs.
(G) Immunoblot analysis of phosphorylated (p-) and total IRF3, phosphorylated (p-) TBK1 and total TBK1, cGAS, STING, Park2, and b-actin (loading control) in
WT and Park2/ MEFs infected for 0, 3 and 6 h (above lanes) with VSV or HSV-1 at MOI 5.
Data are pooled from three independent experiments. Error bars show means G SEM. *p < 0.05, **p < 0.01, NS, not significant. Log rank (Mantel-Cox) test
for survival rates, unpaired t test for viral titers, and two-way ANOVA with Sidak’s multiple comparisons test for RT-qPCR and ELISA analyses. Related to
Figures S1, S2, S6, and S8.mutated gene in PD (Matheoud et al., 2016). Pink1 accumulates on the OMM when mitochondria are
damaged or depolarized and assists the recruitment of Parkin to mitochondria where it ubiquitinates mul-
tiple mitochondrial proteins such as VDAC and TOMs. Ubiquitinated OMM proteins containing K63-linked
polyubiquitin chains are recognized by the ubiquitin-binding domain of the specific autophagy receptor
P62 that also has an LC3-binding domain that recruits LC3 and triggers mitophagy (Jin and Youle, 2012;
Narendra et al., 2008). Thus the Pink1-Parkin pathway plays a key role in initiatingmitophagy and regulating
mitochondrial homeostasis. A recent study found that hepatitis B virus (HBV) can induce mitochondrial
translocation of Parkin and subsequentmitophagy in hepatocytes (Kim et al., 2013). The same group further
showed that during HBV infection the mitochondrially localized Parkin recruits Linear Ubiquitin Assembly
Complex (LUBAC) to the mitochondria, leading to M-1 linked linear ubiquitination of MAVS and blockade
of MAVS-mediated antiviral signaling (Khan et al., 2016). Moreover, during the preparation of this manu-
script, another study reported that Parkin does not target MAVS but promotes K48 linkage ubiquitination
and degradation of TRAF3 to suppress downstream antiviral signaling (Xin et al., 2018). However, these
studies used a combination of overexpression and cell-line-based approaches, and the physiological
role and mechanism of action of the mitophagy protein Parkin in antiviral response remains to be delin-
eated. We now provide insight into the physiological function of Parkin in the host defense against viral
infection while also describing the regulatory role of Parkin-dependent mitophagy in antiviral immunity.
Here we directly investigate the role of Parkin in host antiviral responses by using Parkin knockout mice
(Park2/). We show that Parkin deficiency promotes viral clearance and mice survival after infection with
both RNA and DNA viruses. Interestingly, Parkin does not affect antiviral signaling and interferon (IFN) pro-
duction. Instead we discover that Parkin deficiency increases the innate inflammatory response to viral
infection by augmenting mtROS-mediated NLRP3 activation. Moreover, we find that Parkin expression is
downregulated in human peripheral blood mononuclear cells (PBMCs) during viral infection. These find-
ings clearly demonstrate the importance of tight regulation of Parkin to maximize antiviral immunity.RESULTS
Loss of Parkin Enhances Viral Clearance and Mice Survival but Does Not Affect Type I IFN
Production
To study the physiological role of Parkin in viral infection, we utilized Parkin gene deletion mice (Park2/)
for viral infection studies. First, we intranasally infected mice with vesicular stomatitis virus (VSV), a single-
stranded RNA virus that activates RIG-I-MAVS antiviral signaling. We found that mice lacking Parkin ex-
hibited significantly increased survival through 9 days post infection (dpi) and had lower viral loads in
lung than wild-type (WT) mice after infection (Figure 1A), which is consistent with a previous report that Par-
kin functions as a negative regulator of MAVS antiviral signaling (Khan et al., 2016). Next, we intravenously
infected mice with herpes simplex virus 1 (HSV-1, a DNA virus) to investigate if Parkin has a role in the
response to DNA virus infection. We found that Parkin deficiency in mice also enhanced mice survival
and reduced viral loads after viral infection compared with WT mice (Figure 1B). Given HSV-1 infection-
induced innate antiviral response is independent of MAVS signaling (Paludan et al., 2011), these data470 iScience 16, 468–484, June 28, 2019
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Figure 2. Parkin-Deficient Mice Exhibit an Enhanced Antiviral Inflammatory Response to VSV Infection
(A) Hematoxylin and eosin staining of lung sections from WT and Park2/ mice 3 days after infection with VSV at 2 3 108 plaque-forming unit per mouse
(n = 3). Scale bar, 100 mm.
(B) Immunohistochemical detection of myeloid cells (CD11b+) in lungs of WT and Park2/ mice infected as indicated in (A) (n = 3). Scale bar, 100 mm.
(C) Flow cytometry analysis of the numbers of myeloid cells (CD11b+), inflammatory monocytes (CD11b+Ly6C+), neutrophils (CD11b+Ly6G+), dendritic cells
(CD11b+/CD11c+/MHC II+), T cells (Tcr b+), B cells (B220+), and NK cells (NK1.1+) in lungs of WT and Park2/mice infected as indicated in (A) (n = 6 mice per
group).
(D) ELISA analysis of IL-1b, IL-18, IL-6, CXCL1, and CCL2 of BALF fromWT and Park2/mice infected as indicated in (A) (n = 6 for viral infection, n = 3 for mock
infection).
Data are pooled from three independent experiments. Error bars show means G SEM. *p < 0.05, **p < 0.01, ***p < 0.001. Two-way ANOVA with Sidak’s
multiple comparisons test for ELISA. Related to Figures S3 and S4.suggest that Parkin can play a negative regulatory role in host defense against both RNA and DNA viruses,
and we next addressed the mechanisms underlying these regulatory roles.
Type-1 IFNs play crucial roles in innate antiviral immunity by inducing the expression of hundreds of anti-
viral genes (Takeuchi and Akira, 2010). Because Park2/ mice exhibit a significant increase in viral clear-
ance in vivo, we next sought to assess the effects of Parkin deficiency on IFN-b production. Unexpectedly,
no significant differences in IFN-b production from bronchoalveolar lavage fluid (BALF), sera, and lung ho-
mogenates were detected between WT and Park2/ mice at early time points, such as 12, 24, and 72 h
after VSV or HSV-1 infection (Figures 1A, 1B, and S1A), which is in contrast with the previously reported
role of Parkin as a negative modulator of IFN production in cells (Xin et al., 2018). To further investigate
any direct effect of Parkin on IFN-b production, we examined IFN expression in ex vivo Park2/mouse em-
bryonic fibroblasts (MEFs) challenged with VSV and HSV-1. Parkin-deficient MEFs exhibited similar expres-
sion levels of Ifn transcripts and IFN-b protein as WT MEFs in response to infection with VSV or HSV-1 (Fig-
ures 1C and 1D). Previous study showed that Park2/ mice following exhaustive exercise exhibits
increased mitochondrial DNA (mtDNA) release from damaged mitochondria into cytosol, leading to acti-
vation of cGAS-STING-mediated IFN signaling (Sliter et al., 2018). We thus next investigate the abundance
of mtDNA between WT and Park2/ MEFs. The mtDNA copy number was enhanced after viral infection,
whereas the amount of mtDNA and expression of IFN-stimulated genes was not affected by Parkin defi-
ciency (Figures 1E and 1F). Moreover, we evaluated early antiviral innate signaling after viral stimulation
and observed no obvious differences in virus-induced activation of TBK1 or IRF3 and the protein levels
of cGAS and STING between WT and Park2/ MEFs (Figure 1G). In addition, flow cytometry analysis
showed that WT and Park2/ cells had similar susceptibility to VSV-GFP and HSV-1-GFP viral infection
(Figure S1B) at various time points, which further suggests that Parkin does not affect the susceptibility
of cells to initial viral infection or their ability to respond to viral infection by production of type I IFN. To
further investigate any effect of Parkin on IFN-b production in response to non-replicative IFN inducer
such as RLR ligands, we examined it by using poly(I:C) transfection and found that Parkin deficiency
does not affect IFN production in response to this MAVS-dependent PAMP (Figures S8C and S8D). To
address potential cell type differences, we also assessed the effect of Parkin deficiency in bone marrow-
derived dendritic cells (BMDCs) and bone marrow-derived macrophage cells (BMDMs). Like MEFs, there
were no differences in virus-induced IFN production and IRF3-dependent signaling between WT and
Park2/ BMDCs or BMDMs (Figures S2A–S2E). Collectively, these results clearly indicate that Parkin has
no direct influence on innate antiviral signaling that triggers type I IFN production.
Parkin Deletion Promotes Antiviral Inflammation In Vivo
During viral infection, the initial inflammatory response can contribute to viral clearance by recruiting and
activating immune cells to combat viral invasion (Chen et al., 2011; Rouse and Sehrawat, 2010). Thus, we
next assessed if Parkin can affect antiviral inflammation in an in vivo setting. Histological analysis revealed
that lungs in Park2/ mice contained more severe inflammation characterized by more infiltration of im-
mune cells than lungs from WT mice after the early stage of VSV infection (at 3 dpi) (Figure 2A). This was
further verified by immunohistochemical detection of increased infiltration of CD11b+ myeloid cells in
lungs from Park2/ mice (Figure 2B). Moreover, fluorescence-activated cell sorting (FACS) analysis
showed that Park2/ mice had markedly increased percentages and numbers of CD11b+ cells in lungs
on day 3 after VSV infection compared with WT mice (Figure 2C). In relation to CD11b+ subsets of
cells, inflammatory monocytes (Ly6C+) and neutrophils (Ly6G+) were significantly increased in Park2/
mice. In addition, there were increases in the numbers of monocyte-macrophage DCs (dendritic
cells) (CD11b+/CD11c+/MHC II+), NK cells (NK1.1), T (Tcrb+), and B (B220+) lymphatic cells in lungs of472 iScience 16, 468–484, June 28, 2019
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Figure 3. Parkin-Deficient Mice Exhibit an Enhanced Antiviral Inflammatory Response to HSV-1 Infection
(A) Hematoxylin and eosin staining of lung sections from WT and Park2/ mice 3 days after intravenous injection of HSV-1 (6 3 107 plaque-forming unit per
mouse) (n = 3). Scale bar, 100 mm.
(B) Immunohistochemical detection of myeloid cells (CD11b+) in lungs of WT and Park2/ mice infected as indicated in (A) (n = 3). Scale bar, 100 mm.
(C) Flow cytometry analysis and numbers of myeloid cells (CD11b+), inflammatory monocytes (CD11b+Ly6C+), neutrophils (CD11b+Ly6G+), dendritic cells
(CD11b+/CD11c+/MHC II+), T cells (Tcrb+), B cells (B220+), and NK cells (NK1.1+) in lungs of WT and Park2/mice infected as indicated in (A) (n = 6 mice per
group).
(D) ELISA analysis of IL-1b, IL-18, IL-6, CXCL1, and CCL2 of serum from WT and Park2/ mice infected as indicated in (A) (n = 6 for viral infection, n = 3 for
mock infection).
Data are pooled from three independent experiments. Error bars show means GSEM. *p < 0.05, **p < 0.01, ***p < 0.001. One unpaired t test with Holm-
Sidak method for FACS and two-way ANOVA with Sidak’s multiple comparisons test for ELISA. Related to Figures S3 and S4.Park2/ mice (Figure 2C). Consistent with these results, we found that the production of inflammatory
cytokines and chemokines, including
interleukin (IL)-1b, IL-18, IL-6, CXCL1, and CCL2, were significantly increased in BALF (Figure 2D) and lung
(Figure S3A) of Park2/mice on 3 dpi VSV compared withWTs. These data suggest that Parkin is important
for regulating antiviral inflammation during VSV infection. To determine whether Parkin is involved in the
antiviral inflammatory response against DNA viruses, we next performed histological, immunohistochem-
ical, FACS and ELISA analyses in Park2/ mice challenged with HSV-1 virus. Like VSV infection, the lung
inflammatory histopathology (Figure 3A); the infiltration of immune cells into lung, as evidenced by immu-
nohistochemistry (Figure 3B) and FACS (Figure 3C); and the levels of inflammatory cytokines in sera (Fig-
ure 3D) or lung (Figure S3B) were all markedly increased in Park2/ mice on 3 dpi HSV-1 compared with
WT controls. Altogether, these findings clearly demonstrate that Parkin deletion augments the general
antiviral inflammatory response, which contributes to enhanced viral clearance.
Parkin Deficiency Enhances the Production of Inflammasome-Related Cytokines after Viral
Infection
Although adaptive immunity can contribute to the antiviral inflammatory response (Dorner and Radbruch,
2007; Swain et al., 2012), Parkin deficiency had no effects on the profiles of CD4+, CD8+, CD44+, CD62L+ T
(Figures S4A, S4C, and S4D), and CD19+ B (Figure S4B) lymphatic cells in thymus and spleen, suggesting
that the enhanced antiviral inflammation in Park2/ mice is not associated with differences in cells of the
adaptive immune system. Given our earlier data above demonstrating that CD11b+ myeloid cells repre-
sented the bulk of the lung-infiltrating cell population in Park2/mice at day 3 after viral infection (Figures
2C and 3C) and the essential role of myeloid lineage cells in initiating antiviral inflammation (Varol et al.,
2015), we next investigated the effect of Parkin on the production of virus-induced inflammatory cytokines
in BMDCs. VSV and HSV-1 induced expression of mRNA transcripts of cytokines, such as Il1b, Il18, Il6, and
Il12, were largely comparable between WT and Park2/ cells after viral infection (Figure 4A). In addition,
early signaling pathways, such as activation of NF-kB and p38 mitogen-associated protein kinase, that
mediate virus-induced transcription of these genes, were unaffected in Parkin-deficient cells as evidenced
by intact VSV and HSV-1 induced phosphorylation of IkBa and p38 in Park2/ cells (Figure 4B). However,
Park2/ BMDCs produced higher amounts of inflammasome-related cytokines, including IL-1b and IL-18,
in response to VSV or HSV-1 infection, whereas there were no differences in the virus-induced production of
other cytokines such as IL-6 and IL-12 between WT and Park2/ cells (Figure 4C). These findings suggest
that Parkin in myeloid cells negatively regulates virus-induced production of inflammasome-related cyto-
kines by targeting post-transcriptional regulation of their expression. To extrapolate these findings into a
human setting, we further evaluated the effect of Parkin deficiency on the production of cytokines in the
human monocyte cell line THP-1 after viral infection. THP-1 cells were transfected with small interfering
RNA to knockdown Parkin expression (Figure S5A) and then infected with VSV or HSV-1. The production
of IL-1b and IL-18 was significantly enhanced in Parkin knockdown cells as determined by ELISA assay,
whereas virus-induced expression of other cytokines, such as IL-6 and IFN-b, was not affected (Figure S5B).
Thus, these results confirm that the selective targeting in the production of inflammasome-related cyto-
kines by Parkin applies to murine and human cells. Although Parkin deficiency does not affect viral induced
expression of IL-6 in cell infection studies, it is interesting to note from our earlier data that Park2/ mice
show augmented lung levels of IL-6 in response to viral infection. Such differences in cell- and animal-based
infection approaches are reconciled by previous studies that have shown inflammasome-related cytokines,
such as IL-1b and IL-18, to induce the production of proinflammatory cytokines and chemokines (Brabcova
et al., 2014; Cahill and Rogers, 2008; McGeough et al., 2012; Yoo et al., 2005). Therefore the enhanced474 iScience 16, 468–484, June 28, 2019
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Figure 4. Parkin Deficiency in Myeloid Linage Cells Increases the Production of Inflammasome-Related Cytokines in Response to Viral Infection
(A) RT-qPCR analysis of Il1b, Il18, Il6, and Il12 mRNA expression of WT and Park2/ BMDCs infected with VSV or HSV-1 at MOI 1 for 4, 8, and 12 h. NT, no
treatment.
(B) Immunoblot analysis of phosphorylated (p-) IkBa, phosphorylated (p-) P38, and b-actin (loading control) in WT and Park2/ BMDCs infected for 0, 3, and
6 h with VSV or HSV-1 at MOI 5.
(C) ELISA analysis of IL-1b, IL-18, IL-6, and IL-12 in the supernatants of WT and Park2/ BMDCs infected with VSV at MOI 1 or HSV-1 at MOI 2 for 24 h. NT, no
treatment.
(D) ELISA analysis of IL-1b, IL-18, and TNF-a in the supernatants of Pam3CSK4-primed WT and Park2/ BMDMs treated with ATP for 1 h and infected with
VSV at MOI 1 or HSV-1 at MOI 2 for 24 h. NT, no treatment.
(E) Immunoblot analysis of cleaved IL-1b and caspase-1 in culture supernatants (SN) of Pam3CSK4-primed WT and Park2/ BMDMs stimulated with VSV at
MOI 5 or HSV-1 at MOI 10 for 24 h and immunoblot analysis of the precursors of IL-1b (Pro-IL-1b) and caspase-1 (Pro-caspase1) in lysates of those cells
(lysates).
(F) LDH (lactate dehydrogenase) assay of Pam3CSK4-primed WT and Park2/ BMDMs stimulated as indicated in (D). NT, no treatment.
Data are pooled from three independent experiments (A, C, D, and F) or are representative of two independent experiments (B and E). Error bars show
means G SEM. *p < 0.05, **p < 0.01, ***p < 0.001, NS, not significant. two-way ANOVA with Sidak’s multiple comparisons test. Related to Figure S5.production of IL-6, CXCL1, and CCL2 in lungs of virus-infected Park2/ mice is a likely secondary conse-
quence of the higher amounts of IL-1b and IL-18.
Given that Parkin does not appear to regulate the transcription of genes encoding IL-1b and IL-18, coupled
to a recent report showing that Parkin inhibits ATP-induced NLRP3 inflammasome activation (Zhong et al.,
2016), we next explored if Parkin can affect virus-induced inflammasome activation in BMDMs. To this end,
Pam3CSK4 (TLR2 agonist)-primed BMDMs were challenged with VSV, HSV-1, and ATP as a second signal
control for NLRP3 activation. ELISA analysis showed that IL-1b and IL-18 secretion was markedly
augmented in Park2/ cells relative to WT counterparts after viral infection, whereas the production of tu-
mor necrosis factor (TNF)-a, an inflammasome-independent cytokine, was not affected by Park2 deletion
(Figure 4D). This was further confirmed by western blot analysis showing that the release of mature IL-1b
and caspase-1 in cell supernatants was significantly increased in virus-infected Park2/ cells (Figure 4E).
Moreover, the deficiency of Parkin in BMDMs augmented virus-induced lactate dehydrogenase (LDH)
release (Figure 4F), a measure of pyroptotic cell death that is also triggered by NLRP3 activation. Together,
all these results indicate that Parkin in myeloid lineage cells has a unique role in inhibiting virus-induced
inflammasome activation and subsequent production of IL-1b and IL-18 and pyroptosis.
Parkin Restricts Mitochondrial Damage, mtROS Overproduction, and mtROS-Induced
Inflammasome Activation during Viral Infection
We next probed the mechanism by which Parkin targets activation of the NLRP3 inflammasome. Mitochon-
drial dysfunction induces the production of mtROS that can trigger NLRP3 inflammasome activation (Zhou
et al., 2011). As a central mitophagy regulator, Parkin is linked to the removal of damaged mitochondria
(Youle and Narendra, 2011). We therefore examined whether Parkin could control virus-induced mitochon-
drial dysfunction and mtROS production in BMDMs. To investigate this, we first performed cell fraction-
ation to isolate mitochondrial and cytosolic fractions and used western blot analysis to monitor recruitment
of autophagy proteins such as P62 and lipidated LC3 (LC3II) to damagedmitochondria that are destined for
clearance by mitophagy. Infection of WT BMDMs with VSV or HSV-1 showed mitochondrial enrichment of
the autophagy proteins P62, LC3II, and Parkin, whereas the mitochondrial recruitment of these proteins
was abolished in Parkin-deficient cells (Figure 5A), thus confirming the central role of Parkin in virus-induced
mitophagy. Moreover, we found that loss of Parkin led to more severe virus-induced loss of mitochondrial
membrane potential as indicated by reduced mitochondrial accumulation of the fluorescence dye TMRM
(Figure 5B), indicating the increased mitochondrial damage in Park2/ cells. In addition, FACS analysis
showed that viral infection induced more mtROS production in Park2/ than WT cells (Figure 5C). Consis-
tent with this, the oxidized mtDNA (ox-mtDNA) significantly increased in the cytosol of Park2/ cells after
viral infection (Figure 5D). These data strongly suggest that Parkin inhibits virus-inducedmtROS production
and ox-mtDNA release by restricting accumulation of damaged mitochondria.
ROS produced by damaged mitochondria is required for the production of ox-mtDNA, which is an impor-
tant trigger of NLRP3 inflammasome activation (Yu et al., 2014; Zhong et al., 2018; Zhou et al., 2011). Thus,
we reasoned that mtROSmight be required for increased inflammasome activation in Parkin-deficient cells
after viral infection. To test this hypothesis, we treated macrophages with the mitochondrial-specific anti-
oxidant Mito-Q before viral challenge. Indeed, Mito-Q treatment blocked virus-induced mtROS produc-
tion in WT and Park2/ cells (Figure 5C). Interestingly, the virus-induced secretions of IL-1b and IL-18476 iScience 16, 468–484, June 28, 2019
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Figure 5. Parkin Restricts Mitochondrial Damage, mtROS Overproduction, and mtROS-Induced Inflammasome Activation during Viral Infection
(A) Immunoblot analysis of p62, LC3II, and Park2 in cytosolic and mitochondrial subcellular fractions from Pam3CSK4-primed WT and Park2/ BMDMs
infected with VSV at MOI 5 or HSV-1 at MOI 10 for 5 h.
(B) Microscopic analysis of mitochondrial membrane potential of cells stimulated with VSV or HSV-1 at MOI 1 by TMRM (tetramethylrhodamine, methyl ester)
fluorescence. UI, uninfected. Scale bar, 100 mm.
(C) Flow cytometry analysis of the levels of mitochondria-associated ROS (mtROS) labeled by MitoSOX in Pam3CSK4-primed WT and Park2/ BMDMs
untreated or treated with 50 nM Mito-Q (mitochondrial-specific antioxidant) followed by VSV or HSV-1 infection at MOI 5 for 12 h.
(D) ELISA analysis of 8-OH-dG in the cytosol of Pam3CSK4-primed WT and Park2/ BMDMs treated with VSV and HSV-1 at MOI 10 for 5 h.
(E) ELISA analysis of IL-1b, IL-18, and TNF-a in the supernatants of Pam3CSK4-primedWT and Park2/ BMDMs untreated or treated with 50 nMMito-Q and
then infected with VSV at MOI 1 or HSV-1 at MOI 2 for 24 h (n = 3).
(F) Immunoblot analysis of cleaved IL-1b and caspase-1 in culture supernatants (SN) of Pam3CSK4-primedWT and Park2/BMDMs treated with 50 nMMito-
Q and then infected with VSV at MOI 5 or HSV-1 at MOI 10 for 24 h.
(G) LDH assay of Pam3CSK4-primed WT and Park2/ BMDMs treated as indicated in (E).
Data are pooled from three (D, E, and G) independent experiments or are representative of two independent experiments (A, B, C, and F). Error bars show
means G SEM. *p < 0.05, ***p < 0.001. NS, not significant. Unpaired t test or two-way ANOVA with Sidak’s multiple comparisons test.(Figure 5E) were also reduced by Mito-Q to basal levels in both WT and Park2/ BMDMs, whereas virus-
induced expression of TNF was unaffected by Mito-Q (Figure 5E). The inhibitory effects of Mito-Q on in-
flammasome-mediated cytokine processing was also confirmed by western blot analysis that showed
Mito-Q to block the release of mature IL-1b and caspase-1 in supernatants of virus-infected WT and
Park2/ cells (Figure 5F). Mito-Q also blocked the ability of VSV and HSV-1 to promote cytotoxicity in
both WT and Park2/ cells as demonstrated by greatly reduced release of LDH (Figure 5G). Collectively,
these results indicate that mtROS is required for the enhanced activation of inflammasome in Park2/ cells
after viral infection.
Enhanced Antiviral Inflammation and Viral Clearance in Parkin-Deficient Mice Is Dependent
on NLRP3 Inflammasome
To further confirm if the effect of Parkin on virus-induced inflammasome activation is NLRP3 dependent, we
crossed Park2/ and -Nlrp3/ mice to make double knockout BMDMs and then characterized inflamma-
some activation in these cells. The absence of NLRP3 in Park2/ BMDMs had no effect on virus-induced
mtROS production (Figure 6A), and this is hardly surprising because mtROS production is upstream of
NLRP3. However, VSV or HSV-1-induced release of IL-1b and IL-18 was blocked in Park2/ Nlrp3/ dou-
ble knockout cells with this suppressive effect being selective for inflammasome-related cytokines because
virus-induced production of TNF was fully intact in double knockout cells (Figure 6B). This was further
confirmed by western blot analysis showing that NLRP3 deficiency blocked the secretion of mature IL-1b
and caspase-1 in supernatant of Park2/ cells after viral infection (Figure 6C). Furthermore, the absence
of NLRP3 in double knockout cells also precluded the augmented virus-induced release of LDH that is nor-
mally observed in Park2/ cells (Figure 6D). All these findings are fully consistent with Parkin deficiency
promoting virus-induced inflammasome activation via the mtROS-NLRP3 axis.
It is clear from the above ex vivo-based results that Parkin deletion augments virus-induced inflammation
through the activation of mtROS-NLRP3 axis. To further explore whether the enhanced survival and viral
clearance in Parkin-deficient mice are dependent on NLRP3-activated antiviral inflammation, we next per-
formed infection studies in Parkin and NLRP3 double knockout mice. Notably, we observed that like
NLRP3/ mice, Park2/Nlrp3/ mice exhibited substantial reduction in survival and higher viral loads
in lung after VSV (Figure 7A) and HSV-1 (Figure 7B) challenge compared with WTs, and this is markedly in
contrast to the protected phenotype of Park2/ mice. Histological analysis revealed that there
was much less infiltration of immune cells in lungs of Park2/Nlrp3/ mice compared with WT and
Park2/ mice on day 3 after viral infection (Figure 7C), indicating the impairment of antiviral inflammation
in Park2/NLRP3/ mice. In accordance with these results, VSV- (Figure 7D) and HSV-1- (Figure 7E)
inducedproduction of cytokines and chemokines, including IL-1b, IL-18, IL-6, CXCL1, andCCL2, were signif-
icantly inhibited in BALF or sera from Park2/Nlrp3/mice, further suggesting an absolute NLRP3 depen-
dence for the enhanced antiviral inflammation in Park2/ mice. Altogether, these results clearly demon-
strate that loss of Parkin in mice promotes viral clearance through NLRP3-mediated antiviral inflammation.
Parkin Gene Expression Is Downregulated in PBMCs from Virus-Infected Patients
To further determine the relationship of Parkin with virus infection, we analyzed by qPCR transcriptional
changes in the gene expression of Parkin in BMDMs after virus infection. Unlike upregulated expression478 iScience 16, 468–484, June 28, 2019
Figure 6. NLRP3 Deficiency Inhibits the Overproduction of Inflammasome-Related Cytokines in Parkin-Deficient
Cells during Viral Infection
(A) Flow cytometry analysis of mtROS in Pam3CSK4-primed WT, Park2/, Nlrp3/, and Park2/Nlrp3/ BMDMs
infected with VSV or HSV-1 at MOI 5 for 12 h.
(B) ELISA analysis of IL-1b, IL-18, and TNF-a in the supernatants of Pam3CSK4-primed WT, Park2/, Nlrp3/, and
Park2/Nlrp3/ BMDMs infected with VSV at MOI 1 or HSV-1 at MOI 2 for 24 h.
(C) Immunoblot analysis of cleaved IL-1b and caspase-1 in culture supernatants (SN) of Pam3CSK4-primed WT, Park2/,
Nlrp3/, and Park2/Nlrp3/ BMDMs infected with VSV at MOI 5 or HSV-1 at MOI 10 for 24 h.
(D) LDH assay of Pam3CSK4-primed WT, Park2/, Nlrp3/, and Park2/Nlrp3/ BMDMs infected as in (B).
Data are pooled from three (B and D) independent experiments or are representative of two independent experiments (A
and C). Error bars show means G SEM. *p < 0.05, **p < 0.01, ***p < 0.001, NS, not significant. Two-way ANOVA with
Tukey’s multiple comparisons test. Related to Figure S7.
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Figure 7. NLRP3 Deficiency Reverses the Enhanced Antiviral Inflammation and Viral Clearance in Parkin-Deficient Mice
(A) WT, Park2/, Nlrp3/, and Park2/Nlrp3/ mice (n = 8 mice per group) were intranasally infected with VSV at 2 3 108 plaque-forming unit (PFU) per
mouse or intravenously infected with HSV-1 at 6 3 107 PFU per mouse, and then the survival rates of mice are observed and recorded on the indicated days.
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Figure 7. Continued
(B) Viral titers of lungs fromWT, Park2/,Nlrp3/, and Park2/Nlrp3/mice were determined by standard plaque assay 5 days after infection as indicated
in (A) (n = 6 mice per group).
(C) Hematoxylin-eosin staining of lung sections from WT, Park2/, Nlrp3/, and Park2/Nlrp3/ mice on day 3 after VSV or of HSV-1 infection. (n = 3).
Scale bar, 100 mm.
(D and E) ELISA analysis of IL-1b, IL-18, IL-6, CXCL1, and CCL2 of BALF (D) or serum (E) fromWT, Park2/,Nlrp3/ and Park2/Nlrp3/mice on day 3 after
VSV or of HSV-1 infection (n = 5 per group for viral infection, n = 3 per group for mock infection).
Data are pooled from three independent experiments. Error bars show means G SEM. *p < 0.05, **p < 0.01, ***p < 0.001, NS, not significant. Log rank
(Mantel-Cox) test for survival rates, unpaired t test for viral titers and two-way ANOVA with Tukey’s multiple comparisons test for ELISA.of antiviral cytokines, the expression of Parkin and another mitophagy regulator Pink1 was markedly
reduced in response to VSV or HSV infection (Figure S6A), and this may serve to remove a negative regu-
lator of antiviral inflammation and facilitate an enhanced antiviral response. This is also fully consistent with
our earlier data showing that Parkin expression was downregulated at protein level after viral infection (Fig-
ure 1G). To further explore the relationship of decreased Parkin expression following viral infection with
IFN-b, we treatedWTMEFs and BMDMs with IFN-b. However, the Parkin expression did not decrease, sug-
gesting the independent role of type I IFNs in regulating Parkin expression after viral infection (Figures S8A
and S8B). Thus, how Parkin expression is regulated by host cells following viral infection remains to be
investigated in future. To further explore the relevance of Parkin in the context of clinical infections, we
next sought to assess Parkin expression in white blood cells of humans with virus infection. We isolated
PBMCs from uninfected healthy donors and patients infected with hepatitis C virus (HCV, an RNA virus).
qPCR analysis showed that Parkin gene expression was significantly decreased in PBMCs from virus-in-
fected patients compared with healthy counterparts (Figure S6B). Thus, these data further support a critical
regulatory role of Parkin in controlling the human response to viral infections.
DISCUSSION
Increasing evidence has demonstrated that mitochondria play broad roles in innate immune response,
including their functioning as signal transduction platforms, providing energy and metabolites for inflam-
mation, and generating ROS as modulators of immune response (Weinberg et al., 2015; West et al., 2011).
Mitophagy is a specific form of autophagy that can remove damaged mitochondria and maintain mito-
chondrial homeostasis (Kubli and Gustafsson, 2012). Some studies have reported that mitophagy can con-
trol inflammasome-related inflammation by mediating the clearance of damaged, mtROS-generating
mitochondria (Nakahira et al., 2011; Zhong et al., 2016). We now provide a major insight into the physiolog-
ical role of mitophagy and its regulation of inflammasome-mediated inflammation in the context of antiviral
immunity.
Parkin, a central player in mitophagy, can be recruited to damaged mitochondria and ubiquitylate OMM
proteins to initiate mitophagy (Narendra et al., 2008). A recent study showed that Parkin recruits LUBAC
to mitochondria via interaction with MAVS and inhibits RLR-MAVS signaling (Khan et al., 2016), whereas
another recent study reported the converse result that Parkin fails to interact with MAVS but regulates anti-
viral signaling by controlling TRAF3 stability (Xin et al., 2018). However, these studies were restricted to cell-
based infection models and lacked data to evaluate the physiological or pathophysiological relevance of
Parkin in viral infections. We now provide insight into the role of Parkin in the in vivo response to viral in-
fections. We discover a critical role for Parkin in regulating viral clearance in vivo. Parkin deficiency en-
hances mouse survival in cases of infection with RNA and DNA viruses, and this is associated with improved
viral clearance. Intriguingly, Parkin deficiency did not affect early virus-induced expression of type I IFN pro-
duction either in vivo or in primary cells and the early signaling pathways, like IRFs, that act as upstream
drivers of IFN induction, were also intact in Parkin knockout cells. This contrasts with previous reports using
cell models, which proposed Parkin to be a negative modulator of virus-induced type I IFN production. It is
possible that this difference might be caused by using carcinoma cell lines in previous studies. A recent
study demonstrated that Parkin controlled mtDNA release into cytosol and cGAS-STING-dependent acti-
vation of IFN following exhaustive exercise (Sliter et al., 2018). Although during viral infection Park2/ cells
exhibit the increased release of ox-mtDNA (Figure 5D), much more nuclear acids from virus can mask the
effect of more mtDNA release by Parkin deficiency on cGAS-sting activation, which might explain why
Parkin does not regulate mtDNA-cGAS-STING axis-mediated IFN production after viral infection.
Although our studies question the role, if any, of Parkin in regulating the type I IFN pathway, we clearly high-
light its function in controlling inflammasome-mediated antiviral immunity. Several recent studies haveiScience 16, 468–484, June 28, 2019 481
described a role for the NLRP3 inflammasome in mediating innate immunity to virus. In all of these cases,
NLRP3 promotes antiviral inflammation and viral clearance (Allen et al., 2009; Ichinohe et al., 2009; Thomas
et al., 2009). Moreover, a study in IL-1R-deficient mice has shown that the animals have reduced acute
airway inflammation associated with influenza virus infection and have significantly decreased survival
(Schmitz et al., 2005). A recent study suggested that inflammasome activation can negatively regulate
IFN-b response to DNA viruses through caspase-1-mediated cleavage of cGAS (Wang et al., 2017), whereas
our studies did not find that virus-induced IFN-b was affected in Nlrp3-deficient BMDM (Figures S7A and
S7B). We reasoned that the other inflammasome complex, for example AIM2, but not NLRP3, might be
involved in this regulatory process. Our present studies indicate that Parkin deficiency increases virus-
induced NLRP3 inflammasome activation and related inflammation through defective mitophagy.
Impairedmitophagy results in overproduction of mtROS, which is correlated with increased antiviral inflam-
mation in vivo, better viral clearance, and decreased mortality in mice. Notably, recent studies clearly
demonstrate that in macrophages, the Parkin-p62-mitophagy pathway can dampen NLRP3 inflammasome
activation by NLRP3 agonists by the removal of damaged mitochondria to control mtROS overproduction
(Zhong et al., 2016). We now discover an important role for the mitophagy-inflammasome signaling axis in
the context of antiviral immunity. We propose that in response to viral infection, mtROS is produced by
damaged and depolarized mitochondria leading to NLRP3 activation and antiviral inflammation that is
driven by IL-1b and IL-18. However, Parkin suppresses this antiviral response by promoting the clearance
of damaged mitochondria by the process of mitophagy. Notably we show that under conditions of viral
infection in both experimental and clinical cases the expression of Parkin is suppressed by the virus, thus
relieving a braking system that will lead to accumulation of damaged mitochondria, high levels of
mtROS and NLRP3 activation, and the triggering of NLRP3-driven antiviral inflammation. It is interesting
to speculate that the negative role of Parkin in antiviral inflammation may fill a physiological function
ensuring that persistent infection does not trigger a dysregulated inflammatory response and pathological
tissue injury.
PD is associated with accumulation of damaged and defective mitochondria, which can be the major cause
of neuroinflammation (Winklhofer and Haass, 2010). Indeed, although parkinsonism exhibits age-related
degeneration of dopaminergic neurons, increasing evidence show that excessive inflammation may exac-
erbate neuronal cell death and disease development (Wang et al., 2015). In addition, it has been suggested
that viruses, and in particular influenza virus, can be a precipitating factor in the development of PD (Jang
et al., 2009). We found that viral infections in humans were associated with significant decreases in the
expression levels of Parkin. Given that some genetic forms of PD are associated with mutations in the Parkin
gene, virus-induced suppression of Parkin may phenocopy the pathology associated with Parkin-related
PD. Indeed, impaired mitophagy resulting from Parkin deficiency or virus-induced suppression may link
excessive NLRP3 inflammasome activation in microglia to chronic neuroinflammation that exacerbates
neuronal cell death. Thus the present studies strongly prompt future studies to explore the potential
role of Parkin in virus-related PD.
Taken together, our findings demonstrate a vital role for Parkin and mitophagy in regulating antiviral
inflammation. These pathways act as a brake on virus-induced NLRP3 inflammasome activation by control-
ling mtROS. Our studies thus promote Parkin as a potential therapeutic target in the promotion of antiviral
immunity.Limitations of the Study
Our study clearly demonstrates that Parkin plays an important role in antiviral immunity by controlling
mtROS-NLRP3 axis-mediated inflammation. The decreased expression of Parkin following viral infection
is observed in mice and humans, but how Parkin expression is regulated by host cells following viral infec-
tion remains unknown. The known PD-related Parkin mutants majorly include splice site mutations and
missense mutations. Our study in Parkin-deficient mice can well reflect the effect of slice site mutants on
antiviral response. However, we do not know the relationship of antiviral response withmissensemutations,
which will lead to a loss of Parkin function in E3-ligase catalytic activity. Thus, these issues need to be inves-
tigated in future studies.METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.482 iScience 16, 468–484, June 28, 2019
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.06.008.
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Transparent methods 
Mice 
Park2-/- mice (Strain ID: 006582, C57BL/6 background) were provided by Dr. Jiawei Zhou from 
the Jackson Laboratory. Nlrp3-/- mice on C57BL/6 background were a gift from Dr. V. Dixit 
(Genentech). Park2-/- Nlrp3-/-mice were established by crossing Nlrp3-/- with Park2-/ -mice. Mice 
used in this study (8-10-week-old male mice) were kept and bred under specific-pathogen-free 
conditions. All experiments were performed under protocols approved by the Institutional Animal 
Care and Use Committee of Nanjing Medical University, Guangzhou Medical University and 
Shanghai Institute of Neuroscience, Chinese Academy of Sciences. 
 
Reagents  
IL-18 ELISA capture antibody (D047-3), detection antibody (D048-6) and standard protein 
(12405-1) were from R&D; IFN-ELISA capture antibody (sc-57201) was from Santa Cruz; IFN-
 detection antibody(32400-1) and standard protein (12400-1) were from R&D. Anti-P62(5114), 
anti-LC3B(2775), anti-myc(2276), anti-phosphorylated IRF3(4947s), anti-IRF3(4302s), anti-
TBK1(3013s), anti-phosphorylated TBK1(5483s), anti-phosphorylated IB(9246s) and anti-
phosphorylated P38(9212s) were from Cell Signaling Technology; Anti-flag (F3165), anti-β-
actin(AC-15; A 1978) and anti--tubulin(T9026) were from Sigma; Anti-Parkin (sc-32282) and 
anti-Traf3(sc-949) were from Santa Cruz; Anti-IL-1 (AB-401-NA) was from R&D; Anti-
caspase1 (AG-20B-0042-C100) was from Adipogen. Anti-mouse-HRP and anti-rabbit-HRP were 
from Jackson ImmunoResearch. Anti-CD45-AF700(30-F11,85-11-0112-81), anti-CD11b-
FITC(M1/70,85-12-0114-81), anti-CD11c-PE (N418, 48-9688-82), anti-Ly6C-PE-Cy7(HK1.4,25-
5932-82), anti-Ly6G- eFlour450 (1A8-LY6G, 48-9668-82), anti-TCReFlour450(H57-597, 48-
5961-80), anti-B220-Percp-Cy5.5 (Ra3-6B2,45-0452-82) and anti-NK1.1-PE-Cy7(PK136, 25-
5941-81) antibodies were from eBioscience; MHC II (M5/114.15.2, 107627.0) was from 
Biolegend. Pam3CSK4 (tlrl-pms) and Poly(I:C) (tlrl-picw) were from Invivogen. Mito-Q was 
from MCE(HY-100116). Ficoll was from GE Health (45-001-749). 
 
Viruses  
VSV (Indiana strain) and HSV-1 (KOS strain) were obtained from Dr. Yichuan Xiao (Shanghai 
Institutes for Biological Sciences, China). VSV-GFP and HSV-1-GFP were from Dr. Tao Peng. All 
viruses were amplified by infection of a monolayer of African green monkey kidney cells (Vero). 
Briefly, 24-48 h after infection, the infected cells were frozen and thawed for three times to release 
virus. Then the cell lysate and culture supernatant were harvested and clarified by centrifugation. 
Viral titers were determined by standard plaque assay on confluent monolayers of Vero cells. 
 
Viral infection in vivo 
Age matched male mice (8-10-week old) were intranasally infected with VSV at 2×108 pfu per 
mouse or intravenously infected with HSV-1 at 6×107 pfu per mouse. Lungs from inoculated 
animals were homogenized in PBS and assayed for viral loads by plaque assay on Vero cells. Serum, 
BALF and lungs were also collected for Elisa, histology and FACS analysis. 
 
Plaque Assay for Virus Titers 
Viral infectivity was quantified using Vero cell monolayer. In brief, several 10-fold serial dilutions 
of the samples were made, added to Vero cell monolayer and incubated for 1–2 days. Then the 
cells were fixed and stained with 0.1% crystal violet solution for 10 min. Plaques were counted 
and viral titers were determined as plaque-forming units per ml by multiplying the dilution factor. 
For assay of viral load in mouse organs, after mice were sacrificed organs were collected 
individually, disrupted with a tissue homogenizer, frozen, and thawed three times to release the 
virus. Serial dilutions were made of the organ homogenates and then subjected to plaque assay. 
 
Cell preparation and stimulation 
MEFs were generated from E12-14 embryos, maintained in DMEM supplemented with 10% FBS, 
and sub-cultured no more than five passages before experiments. For isolation of BMDMs and 
BMDCs, tibias and femurs were removed from mice by sterile techniques and bone marrow was 
flushed with fresh medium. BMDMs were cultured in DMEM supplemented with 10% FBS in the 
presence of 10% L929 conditioned medium. BMDCs were cultured in RPMI-1640 complemented 
with 10% FBS in the presence of 10% J558 culture medium. After 5 days culture, 1.5×106 
BMDMs and BMDCs were plated overnight in 12-well plates and were infected with VSV and 
HSV-1 as indicated in legends. For inducing inflammasome activation, BMDMs were primed with 
1g/mL Pam3CSK4 for 3 h and then stimulated with ATP (2.5 mM) for 1 hour or with VSV and 
HSV-1 as indicated MOI for 24 h. THP-1 cells were cultured in RPMI-1640 medium plus 
GlutaMAX-I medium (Gibco) and transfected with control or Parkin-specific siRNA for 48hr. The 
following siRNA sequences were used: Con-siRNAs UUCUCCGAACGUGUCACGUTT, Con-
siRNAas ACGUGACACGUUCGGAGAATT; Park2-siRNAs 
CGACCCUCAACUUGGCUACTT, Park2-siRNAas GUAGCCAAGUUGAGGGUCGTT. The 
knockdown cells were then infected with VSV and HSV-1 for indicated times. 
 
Immunoblotting  
Cells were grown in 12-well plates and after treatment were then collected in 120l NP-40 lysis 
buffer (50 mM Tris-HCl, pH 7.4, containing 150 mM NaCl, 1% (vol/vol) Igepal, 10% (wt/vol) 
glycerol, 50 mM NaF, 1 mM Na3VO4, 1 mM dithiothreitol, 1 mM phenylmethylsulphonyl fluoride 
and complete protease-inhibitor 'cocktail' (Sigma)), followed by incubation for 30 min at 4 °C. Cell 
lysates were initially precleared by centrifugation at 14000 rpm. An aliquot of 6X SDS-PAGE 
sample buffer (1M Tris-HCl, pH 6.8, 20% (w/v) glycerol, 4% (w/v) SDS, 3% (w/v) DTT and 0.02% 
(w/v) bromophenol blue) was added to cell lysates. Samples were resolved by SDS-PAGE, 
transferred to nitrocellulose membranes and analyzed by immunoblot with the appropriate 
antibodies. Immunoreactivity was visualized by the Odyssey Imaging System (LI-COR Biosciences) 
or enhanced chemiluminescence. 
 
Measurement of cytosolic mtDNA  
WT and Park2-/- MEFs were infected with VSV and HSV-1 (MOI=10) for 4h.Total DNA was 
isolated from the indicated cells using E.Z.N.A.TM MicroElute Genomic DNA kit (OMEGA) 
according to manufacturer’s instructions. mtDNA was quantified by qPCR using primers specific 
for the mitochondrial D-loop region or a specific region of mtDNA that is not inserted into nuclear 
DNA (non-NUMT). Nuclear DNA encoding Tert and B2m was used for normalization.  
D-loop F: 5′AATCTACCATCCTCCGTGAAACC3′; 
D-loop R: 5′TCAGTTTAGCTACCCCCAAGTTTAA3′ 
Tert F: 5′CTAGCTCATGTGTCAAGACCCTCTT3′ 
Tert R: 5′GCCAGCACGTTTCTCTCGTT3′ 
B2m F: 5′ATGGGAAGCCGAACATACTG3′ 
B2m R: 5′CAGTCTCAGTGGGGGTGAAT3′ 
non-NUMT F: 5′CTAGAAACCCCGAAACCAAA3′ 
non-NUMT R: 5′CCAGCTATCACCAAGCTCGT3′ 
 
Measurement of cytosolic 8OH-dG 
WT and Park2-/- BMDMs were primed with 1g/mL Pam3CSK4 for 3 hr and then stimulated with 
VSV and HSV-1(MOI=10) for 5h. Cellular fractionation was then performed using a 
mitochondrial isolation kit for cultured cells according to manufacturer’s instructions. Cytosolic 
protein concentration and volume of the supernatant were normalized, DNA was isolated from 
300ul cytosolic fractions using E.Z.N.A.TM MicroElute Genomic DNA kit according to 
manufacturer’s instructions. The 8OH-dG was quantified using 8OH-dG ELISA kit (Elabscience), 
as the manufacturer’s instruction. 
 
RT-qPCR assays 
Total RNA was extracted with Trizol reagent (Invitrogen) and reversed-transcribed with Reverse 
Transcription System (Vazyme). Reverse transcription products of different samples were 
amplified by Steponeplus (Applied Biosystems) using Brilliant SYBR Green QPCR Master mix 
(Vazyme) according to the manufacturer's instructions and data were normalized by the level of 
HPRT expression in each individual sample. 2-Ct method was used to calculate relative 
expression changes. Heatmap analysis was carried out using MeV Experiment View software. The 
following primers were used:   
 
Mouse Il1b S As 
 5 ATGCCACCTTTTGACAGTGATG 3 5 GTTGATGTGCTGCTGCGAGA 3 
Mouse Il6 S As 
 5 CTTGGGACTGATGCTGGTGAC 3 5 GCCATTGCACAACTCTTTTCTC 3 
Mouse Il18 S As 
 5 TCAAAGTGCCAGTGAACCCC 3 5 AGGGTCACAGCCAGTCCTCTT 3 
Mouse Il12 S As 
 5 TGGTTTGCCATCGTTTTGC 3 5 GGGAGTCCAGTCCACCTCTACA 3 
Mouse Irf7 S As 
 5 CAGCACAGGGCGTTTTATCTT 3 5 TCTTCCCTATTTTCCGTGGC 3 
Mouse Isg15 S As 
 5 AGCAGATTGCCCAGAAGATTG 3 5 CCCCTTTCGTTCCTCACCA 3 
Mouse Ifna S As 
 
5 CTTTCCTCATGATCCTGGTAATGAT 3   
5 AATCCAAAATCCTTCCTGTCCTTC 
3 
Mouse Ifnb S  AS 
 5 CCCTATGGAGATGACGGAGA 3 5 CCCAGTGCTGGAGAAATTGT 3 
Mouse Ndufa6 S  AS 
 5ACGGCAGCGAGTCCCGTGGCACCGC3 5 GTGTCCGCTGCTTCCATACTT 3 
Mouse 
Ndufab1 
S  AS 
 5TGGGTTGGCGTAGCCATGGCGTCTC 3 5 TCGGTCCTTGATTCCGTCTAAC  3 
Mouse Hprt S AS 
 5 GTCCCAGCGTCGTGATTAGC 3 5 TGGCCTCCCATCTCCTTCA 3 
Mouse Ddx58 S AS 
 5 CACATTTGCGGAAATACAACG 3 5 TGCTGCTTCTCGGACATCG 3 
Moues Isg15 S AS 
 5 AGCAGATTGCCCAGAAGATTG 3 5 CCCCTTTCGTTCCTCACCA 3 
Mouse Stat1 S AS 
 5 TCACAGTGGTTCGAGCTTCAG 3 5 GCAAACGAGACATCATAGGCA 3 
Human Park2 S  AS 
 5 ATGATAGTGTTTGTCAGGTTCAACT 3 5 CCCTGTCGCTTAGCAACCA 3 
Human Pink1 S AS 
 5ATGGCGGTGCGACAGGCGCTGGGCC3 5 CGGCTTGCTTTTCTGGGTAA 3 
Human Hprt S AS 
 5 GGCGATGTCAATAGGACTCCAGAT 3 5 GGTGAAAAGGACCCCACGAA3 
 
 
ELISA 
Primary mouse cells were stimulated as indicated. Conditioned media were collected and 
measured for levels of IL-1(DY401), TNF-(DY410) and IL-12 (DY2398) according to 
manufacturer’s instructions (R&D Systems). The level of IL-18 and IFN-β was assayed by an in-
house sandwich ELISA system. The serum, BALF and lung from wild-type and Park2−/− mice 
were collected after infection as indicated and the levels of IL-1β, IL-18, IL-6(DY406), CXCL1 
(DY453) and CCL2 (DY479) in these samples were measured by sandwich ELISA (R&D 
Systems). Conditioned supernatants from human THP-1 siRNA-transfected cells were assayed for 
IL-1β (DY201, R&D), IL-6 (DY206, R&D), IL-18(70-EK1181, Multi Sciences) and IFN-β (70-
EK1236-48, Multi Sciences). 
 
Cytotoxicity Assay (LDH)  
Conditioned medium from treated BMDMs was assessed for LDH release using Pierce LDH 
Cytotoxicity Assay Kit (Promega) according to the manufacturer’s instructions. Relative LDH 
release was calculated as LDH release [%] = 100 * (measurement – unstimulated control)/ (lysis 
control – unstimulated control).  
 
Fluorescence and Confocal microscopy 
BMDMs were seeded on slides overnight and then were stimulated as indicated. After being 
stained with TMRM (20 nM) in the dark for 30 minutes at 37 °C, the cells were fixed, washed 
three times with PBS and then followed by Hoechst for 5 min. Images were captured using 
Nikon50i fluorescent microscope.  
 
Flow cytometry  
For isolation of lung infiltrating immune cells, mice on day 3 after viral infection were 
anesthetized and perfused with 10-15 mL of PBS (ice cold) through the right ventricle until lungs 
cleared of blood. Lungs were harvested, cut into small pieces and incubated in collagenase type IV 
(0.5mg/ml) and DNase I (10U/ml) at 37°C under agitation (200 rpm) conditions for 90 min. The 
digested tissues were filtered through a 100 m filter and the plunger end of syringe was used to 
push the cells over the filter. Homogeneous cell suspensions were centrifuged over a 40%/80% 
discontinuous Percoll gradient (GE Healthcare), mononuclear cells were isolated from the 
interface. The cells were suspended in PBS containing 2% (w/v) FBS. Once lysed in RBC lysis 
buffer, cells were washed with the suspension buffer and stained with fluorochrome-conjugated 
surface marker antibodies for FACS analysis. The following antibodies were used: CD45, CD11b, 
ly6C, ly6G, MHC II+, CD11c, TCR, B220 and NK1.1. Mitochondria-associated ROS levels were 
measured by staining cells with MitoSOX (Invitrogen) at 2.5 μM for 30 min at 37 °C. Cells were 
then washed with PBS solution and re-suspended in cold PBS solution containing 1% FBS for 
FACS analysis. All flow cytometry was performed on an Attune NxT flow cytometer 
(Thermofisher) and data were analyzed by FlowJo 7.6.1 software. 
 
Histology and Immunohistochemistry 
Lungs from control or virus-infected mice were fixed in 10% phosphate-buffered formalin, 
embedded into paraffin and sectioned. Sections of lung 5 μm in thickness were collected on 
superfrost slides, deparaffinized in xylol and rehydrated, and stained with hematoxylin-eosin 
(H&E) solution y. For immunohistochemical staining, sections were blocked and incubated with 
primary antibodies and horseradish peroxidase-conjugated secondary antibodies after heat induced 
antigen retrieval. Diaminobenzidine was used for detection. Images were captured with Nikon 50i 
microscope. 
 
Analysis of PBMC samples from patients with viral infection 
Individuals diagnosed with HCV infection and healthy volunteers were enrolled in this study. 
Clinical parameters and characterization of these patients were determined by a physician (GY. 
Liu). Blood samples were collected during severe illness. PBMCs were isolated by Ficoll-
density gradient centrifugation (GE Healthcare). Total RNA was extracted with Trizol reagent 
(Invitrogen) and reversed-transcribed with Reverse Transcription System (Vazyme). This study 
was approved by the institution review board at the First Affiliated Hospital of Nanjing Medical 
University. All patient managements and blood sample collection were carried out in 
accordance with the relevant guidelines. The following table was information of human subjects. 
Name State The sex Age 
Hu HCV  female 32 
Jiang HCV  female 41 
Lu HCV female 27 
Han HCV female 28 
Su HCV female 37 
Sun HCV female 26 
Wang HCV female 49 
Lv HCV female 33 
Liu Healthy female 24 
Wu Healthy female 26 
Hu Healthy male 25 
Zhang Healthy male 26 
Rao Healthy male 27 
Long Healthy male 26 
Yang Healthy male 23 
Wang Healthy male 26 
 
Statistical Analysis 
Data are presented as the mean ± standard error of the mean (SEM). Samples were analyzed 
using unpaired t-test for two groups and ANOVA for multiple groups. Survival curves were 
generated via the product-limit method of GraphPad. In all cases, a P value of less than 0.05 was 
considered statistically significant. 
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Figure S1. Loss of Parkin doesn’t affect IFN production in viral-infected mice, susceptibility 
of MEFs to VSV or HSV-1 infection, Related to Figure 1.
(A) ELISA analysis of IFN-b of lung homogenates from WT and Park2-/- mice infected with the 
indicated viruses for 3 days (n=8 for viral infection, n=3 for mock infection).
(B) Flow cytometry analysis of GFP expression in WT and Park2-/- MEFs infected with VSV-GFP 
and HSV-1-GFP at MOI 1 for 6,12 and 24 h. NT, No treatment
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Figure S2. Parkin deficiency doesn’t affect antiviral signaling and IFN production in BMDCs 
and BMDMs, Related to Figure 1.
(A) RT-qPCR analysis of Ifnb mRNA of WT and Park2-/- BMDCs infected with VSV or HSV-1 for 4, 
8 and12h. NT, No treatment
(B) ELISA of IFN-b in the supernatants of WT and Park2-/- BMDCs infected with VSV or HSV-1 for 
12 and 24h. NT, No treatment
(C) Immunoblot analysis of phosphorylated (p-) and total IRF3, STING and cGAS in WT and Park2-
/-BMDCs infected for 0, 3 or 6h with VSV or HSV-1. 
(D) RT-qPCR analysis of Ifnb and Il6 mRNA of WT and Park2-/- BMDMs infected with VSV or 
HSV-1 for 4, 8 and12h. NT, No treatment
(E) Immunoblot analysis of phosphorylated (p-) and total IRF3, STING, cGAS and b-actin (loading 
control) in WT and Park2-/-BMDMs infected for 0, 3 or 6h with VSV or HSV-1.
Data are pooled from three independent experiments (A, B and D) or are representative of two 
independent experiments (C and E). Error bars show means ± SEM. NS, not significant. two-way 
ANOVA with Sidak’s multiple comparisons test.
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Figure S3. Parkin deficiency enhances viral-induced expression of pro-inflammatory 
cytokines in lung, Related to Figure 2 and 3.
(A) ELISA analysis of IL-1b, IL-18, IL-6, CXCL1 andCCL2 of lungs from WT and 
Park2-/-mice infected with VSV for 3 days (n=6 for viral infection, n=3 for mock 
infection). 
(B) ELISA analysis of IL-1b, IL-18, IL-6, CXCL1, CCL2 of lungs from WT and Park2-/-
mice infected with HSV-1 for 3 days (n=6 for viral infection, n=3 for mock infection). 
Data are pooled from three independent experiments. Error bars show means ± SEM. * * 
P < 0.01, * * * P < 0.001. Two-way ANOVA with Sidak’s multiple comparisons test.
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Figure S4. Parkin deficiency doesn’t affect lymphoid cells, Related to Figure 2 and 3. 
Flow cytometry analysis of percentages and numbers of lymphoid cells in thymus and spleen 
of WT or Park2-/- mice at 10 weeks of age.
(A) CD4+, CD8+ and CD4+CD8+ T cells in thymus.
(B) CD19+ B cells in spleen.
(C) CD4+ CD44+ and CD4+ CD62l+ T cells in spleen.
(D) CD8+ CD44+ and CD8+ CD62l+ T in spleen. 
N=3. Error bars show means ± SEM. NS, not significant. Unpaired t test.
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Figure S5. Parkin knockdown in THP1 cells doesn’t affect IFN production but increases the 
production of inflammasome-related cytokines in response to viral infection, Related to Figure 
4.
(A) RT-qPCR analysis of Park2 mRNA of THP1 cells transfected with control scramble or Park2-
specific siRNA for 48h.
(B) ELISA analysis of IL-1b, IL-18, IL-6 and IFN-β in the supernatants of THP1 cells transfected 
with control scramble or Parkin-specific siRNA for 48h and then infected with VSV at MOI 1 or 
HSV-1 at MOI 2 for 24h. 
Data are pooled from three independent experiments. Error bars show means ± SEM. * P < 0.05, * * 
P < 0.01, NS, not significant. Two-way ANOVA with Sidak’s multiple comparisons test. 
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Figure S6. Parkin gene decrease in response to virus infection in BMDMs and PBMCs of 
patients, Related to Figure 1.
(A) Heatmap visualization of gene expression for Park2, Pink1, P62, Irf7, Isg15, Ifnb, Ifna, Il1b, 
Il6, Cxcl1, Tnfa, Ndufab1 and Ndufa6 in BMDMs infected with VSV or HSV-1 for 6h determined 
by qPCR (log2 fold values). The abundance of each mRNA was normalized relative to PCR of the 
housekeeping gene hprt.
(B) RT-qPCR analysis of Park2 and Pink1 mRNA expression of PBMCs from healthy and HCV 
patients (log2 fold values).
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Figure S7. NLRP3 deficiency in BMDMs doesn’t affect IFN production in response to viral 
infection, Related to Figure 6. 
(A) RT-qPCR analysis of Ifnb mRNA of WT and Nlrp3-/- BMDCs infected with VSV or HSV-1 at 
MOI 1for 12h. 
(B) ELISA of IFN-b in the supernatants of WT and Nlrp3-/- BMDCs infected with VSV or HSV-1 at 
MOI 1 for 24h.
Data are pooled from three independent experiments. Error bars show means ± SEM. NS, not 
significant. two-way ANOVA with Sidak’s multiple comparisons test.
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Figure S8. The independent role of type I IFNs in regulating Parkin expression in response to 
virus infection, and IFN production in response to RLR non replicative IFN inducer, Related 
to Figure 1.
(A) Immunoblot analysis of phosphorylated (p-) STAT1, Park2 and β-actin (loading control) in WT 
BMDMs treated with IFNβ (500U/ml) for 0,0.5, 1, 3 and 6h.                                                                  
(B) Immunoblot analysis of phosphorylated (p-) STAT1, Park2 and β-actin (loading control) in WT 
MEFs treated with IFNβ (500U/ml)for 0,0.5, 1, 3 and 6h.
(C) RT-qPCR analysis of Ifnb mRNA expression of WT and Park2-/- MEFs transfected with 
Poly(I:C) (10ug/ml) for 6h. NT, No treatment. TF: Transfect.
(D) ELISA analysis of IFN-b protein expression of WT and Park2-/- MEFs transfected with 
Poly(I:C) (10ug/ml) for 18h. NT, No treatment. TF: Transfect.
Data are pooled from three independent experiments. Error bars show means ± SEM. NS, not 
significant. Two-way ANOVA with Sidak’s multiple comparisons test.
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